| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |